Learn More About FastWave and its Proven Team with Deep Interventional Experience
Learn More About FastWave and its Proven Team with Deep Interventional Experience
Learn More About FastWave and its Proven Team with Deep Interventional Experience
February 2021
FastWave established as a stand-alone Delaware C-corp.
February 2021
FastWave established as a stand-alone Delaware C-corp.
February 2021
FastWave established as a stand-alone Delaware C-corp.
February 2021
FastWave established as a stand-alone Delaware C-corp.
August 2021
FastWave raises $12M Series A round of financing.
November 2022
USPTO grants FastWave its first utility patent within 6 months of filing.
April 2023
USPTO grants FastWave its second IVL utility patent.
June 2023
FastWave closes oversubscribed private financing round within a few weeks.
Leadership
Scott Nelson
Co-Founder and CEO
Serial entrepreneur with 20 years of medtech & healthtech experience at multinational strategics and high-growth startups.
Tristan Tieso
COO and Program Lead
Former VP of Operations at Worrell with 15+ years of experience in medical device engineering and project management.
Lauren Fischer, MS
Program Manager
10+ years of experience managing interventional development programs at Abbott, Nextern, and Vention Medical.
Curt Goreham-Voss, PhD
Principal Engineer
Biomedical engineer with 10 years of cardiovascular device experience leading highly-technical development programs.
Lisa Pritchard
Regulatory Lead
30+ years of global regulatory experience managing IDEs, Breakthrough Device Designations, 510(k)s, De Novos, PMAs, and EUAs.
Nichole Leahy-Glass
Quality Lead
Biomedical engineer with 10+ years of global quality affairs experience and former VP of Operations and RA/QA at G&H Ortho.
Christina Portz
Clinical Lead
20+ years of clinical affairs experience and previous management roles at Philips, Covidien, and Boston Scientific.
Peter Schneider, MD
Vascular Surgeon
Co-founder of Cagent Vascular and Intact Vascular and scientific advisor to Abbott, Boston Scientific, and Medtronic.
Art Lee, MD
Interventional Cardiologist
Highly accomplished interventionalist with deep clinical research experience and advisor to many cardiovascular companies.
Brady Hatcher
Board Director
Founder of 10+ medtech startups, inventor on dozens of issued patents, and catalyst for multiple successful company exits.
JC Sun, PhD, MBA
Board Director
Extensive equity transaction experience with hundreds of millions in closings as sell-side advisor for many medtech startups.
Scott Nelson
Co-Founder and CEO
Serial entrepreneur with 20 years of medtech & healthtech experience at multinational strategics and high-growth startups.
Tristan Tieso
COO and Program Lead
Former VP of Operations at Worrell with 15+ years of experience in medical device engineering and project management.
Lauren Fischer, MS
Program Manager
10+ years of experience managing interventional development programs at Abbott, Nextern, and Vention Medical.
Curt Goreham-Voss, PhD
Principal Engineer
Biomedical engineer with 10 years of cardiovascular device experience leading highly-technical development programs.
Lisa Pritchard
Regulatory Lead
30+ years of global regulatory experience managing IDEs, Breakthrough Device Designations, 510(k)s, De Novos, PMAs, and EUAs.
Nichole Leahy-Glass
Quality Lead
Biomedical engineer with 10+ years of global quality affairs experience and former VP of Operations and RA/QA at G&H Ortho.
Christina Portz
Clinical Lead
20+ years of clinical affairs experience and previous management roles at Philips, Covidien, and Boston Scientific.
Peter Schneider, MD
Vascular Surgeon
Co-founder of Cagent Vascular and Intact Vascular and scientific advisor to Abbott, Boston Scientific, and Medtronic.
Art Lee, MD
Interventional Cardiologist
Highly accomplished interventionalist with deep clinical research experience and advisor to many cardiovascular companies.
Brady Hatcher
Board Director
Founder of 10+ medtech startups, inventor on dozens of issued patents, and catalyst for multiple successful company exits.
JC Sun, PhD, MBA
Board Director
Extensive equity transaction experience with hundreds of millions in closings as sell-side advisor for many medtech startups.
Scott Nelson
Co-Founder and CEO
Serial entrepreneur with 20 years of medtech & healthtech experience at multinational strategics and high-growth startups.
Tristan Tieso
COO and Program Lead
Former VP of Operations at Worrell with 15+ years of experience in medical device engineering and project management.
Lauren Fischer, MS
Program Manager
10+ years of experience managing interventional development programs at Abbott, Nextern, and Vention Medical.
Curt Goreham-Voss, PhD
Principal Engineer
Biomedical engineer with 10 years of cardiovascular device experience leading highly-technical development programs.
Lisa Pritchard
Regulatory Lead
30+ years of global regulatory experience managing IDEs, Breakthrough Device Designations, 510(k)s, De Novos, PMAs, and EUAs.
Nichole Leahy-Glass
Quality Lead
Biomedical engineer with 10+ years of global quality affairs experience and former VP of Operations and RA/QA at G&H Ortho.
Christina Portz
Clinical Lead
20+ years of clinical affairs experience and previous management roles at Philips, Covidien, and Boston Scientific.
Peter Schneider, MD
Vascular Surgeon
Co-founder of Cagent Vascular and Intact Vascular and scientific advisor to Abbott, Boston Scientific, and Medtronic.
Art Lee, MD
Interventional Cardiologist
Highly accomplished interventionalist with deep clinical research experience and advisor to many cardiovascular companies.
Brady Hatcher
Board Director
Founder of 10+ medtech startups, inventor on dozens of issued patents, and catalyst for multiple successful company exits.
JC Sun, PhD, MBA
Board Director
Extensive equity transaction experience with hundreds of millions in closings as sell-side advisor for many medtech startups.
Scott Nelson
Co-Founder and CEO
Serial entrepreneur with 20 years of medtech & healthtech experience at multinational strategics and high-growth startups.
Tristan Tieso
COO and Program Lead
Former VP of Operations at Worrell with 15+ years of experience in medical device engineering and project management.
Lauren Fischer, MS
Program Manager
10+ years of experience managing interventional development programs at Abbott, Nextern, and Vention Medical.
Curt Goreham-Voss, PhD
Principal Engineer
Biomedical engineer with 10 years of cardiovascular device experience leading highly-technical development programs.
Lisa Pritchard
Regulatory Lead
30+ years of global regulatory experience managing IDEs, Breakthrough Device Designations, 510(k)s, De Novos, PMAs, and EUAs.
Nichole Leahy-Glass
Quality Lead
Biomedical engineer with 10+ years of global quality affairs experience and former VP of Operations and RA/QA at G&H Ortho.
Christina Portz
Clinical Lead
20+ years of clinical affairs experience and previous management roles at Philips, Covidien, and Boston Scientific.
Peter Schneider, MD
Vascular Surgeon
Co-founder of Cagent Vascular and Intact Vascular and scientific advisor to Abbott, Boston Scientific, and Medtronic.
Art Lee, MD
Interventional Cardiologist
Highly accomplished interventionalist with deep clinical research experience and advisor to many cardiovascular companies.
Brady Hatcher
Board Director
Founder of 10+ medtech startups, inventor on dozens of issued patents, and catalyst for multiple successful company exits.
JC Sun, PhD, MBA
Board Director
Extensive equity transaction experience with hundreds of millions in closings as sell-side advisor for many medtech startups.
Scott Nelson
Co-Founder and CEO
Serial entrepreneur with 20 years of medtech & healthtech experience at multinational strategics and high-growth startups.
Tristan Tieso
COO and Program Lead
Former VP of Operations at Worrell with 15+ years of experience in medical device engineering and project management.
Lauren Fischer, MS
Program Manager
10+ years of experience managing interventional development programs at Abbott, Nextern, and Vention Medical.
Curt Goreham-Voss, PhD
Principal Engineer
Biomedical engineer with 10 years of cardiovascular device experience leading highly-technical development programs.
Lisa Pritchard
Regulatory Lead
30+ years of global regulatory experience managing IDEs, Breakthrough Device Designations, 510(k)s, De Novos, PMAs, and EUAs.
Nichole Leahy-Glass
Quality Lead
Biomedical engineer with 10+ years of global quality affairs experience and former VP of Operations and RA/QA at G&H Ortho.
Christina Portz
Clinical Lead
20+ years of clinical affairs experience and previous management roles at Philips, Covidien, and Boston Scientific.
Peter Schneider, MD
Vascular Surgeon
Co-founder of Cagent Vascular and Intact Vascular and scientific advisor to Abbott, Boston Scientific, and Medtronic.
Art Lee, MD
Interventional Cardiologist
Highly accomplished interventionalist with deep clinical research experience and advisor to many cardiovascular companies.
Brady Hatcher
Board Director
Founder of 10+ medtech startups, inventor on dozens of issued patents, and catalyst for multiple successful company exits.
JC Sun, PhD, MBA
Board Director
Extensive equity transaction experience with hundreds of millions in closings as sell-side advisor for many medtech startups.
Scott Nelson
Co-Founder and CEO
Serial entrepreneur with 20 years of medtech & healthtech experience at multinational strategics and high-growth startups.
Tristan Tieso
COO and Program Lead
Former VP of Operations at Worrell with 15+ years of experience in medical device engineering and project management.
Lauren Fischer, MS
Program Manager
10+ years of experience managing interventional development programs at Abbott, Nextern, and Vention Medical.
Curt Goreham-Voss, PhD
Principal Engineer
Biomedical engineer with 10 years of cardiovascular device experience leading highly-technical development programs.
Lisa Pritchard
Regulatory Lead
30+ years of global regulatory experience managing IDEs, Breakthrough Device Designations, 510(k)s, De Novos, PMAs, and EUAs.
Nichole Leahy-Glass
Quality Lead
Biomedical engineer with 10+ years of global quality affairs experience and former VP of Operations and RA/QA at G&H Ortho.
Christina Portz
Clinical Lead
20+ years of clinical affairs experience and previous management roles at Philips, Covidien, and Boston Scientific.
Peter Schneider, MD
Vascular Surgeon
Co-founder of Cagent Vascular and Intact Vascular and scientific advisor to Abbott, Boston Scientific, and Medtronic.
Art Lee, MD
Interventional Cardiologist
Highly accomplished interventionalist with deep clinical research experience and advisor to many cardiovascular companies.
Brady Hatcher
Board Director
Founder of 10+ medtech startups, inventor on dozens of issued patents, and catalyst for multiple successful company exits.
JC Sun, PhD, MBA
Board Director
Extensive equity transaction experience with hundreds of millions in closings as sell-side advisor for many medtech startups.
Scott Nelson
Co-Founder and CEO
Serial entrepreneur with 20 years of medtech & healthtech experience at multinational strategics and high-growth startups.
Tristan Tieso
COO and Program Lead
Former VP of Operations at Worrell with 15+ years of experience in medical device engineering and project management.
Lauren Fischer, MS
Program Manager
10+ years of experience managing interventional development programs at Abbott, Nextern, and Vention Medical.
Curt Goreham-Voss, PhD
Principal Engineer
Biomedical engineer with 10 years of cardiovascular device experience leading highly-technical development programs.
Lisa Pritchard
Regulatory Lead
30+ years of global regulatory experience managing IDEs, Breakthrough Device Designations, 510(k)s, De Novos, PMAs, and EUAs.
Nichole Leahy-Glass
Quality Lead
Biomedical engineer with 10+ years of global quality affairs experience and former VP of Operations and RA/QA at G&H Ortho.
Christina Portz
Clinical Lead
20+ years of clinical affairs experience and previous management roles at Philips, Covidien, and Boston Scientific.
Peter Schneider, MD
Vascular Surgeon
Co-founder of Cagent Vascular and Intact Vascular and scientific advisor to Abbott, Boston Scientific, and Medtronic.
Art Lee, MD
Interventional Cardiologist
Highly accomplished interventionalist with deep clinical research experience and advisor to many cardiovascular companies.
Brady Hatcher
Board Director
Founder of 10+ medtech startups, inventor on dozens of issued patents, and catalyst for multiple successful company exits.
JC Sun, PhD, MBA
Board Director
Extensive equity transaction experience with hundreds of millions in closings as sell-side advisor for many medtech startups.
Scott Nelson
Co-Founder and CEO
Serial entrepreneur with 20 years of medtech & healthtech experience at multinational strategics and high-growth startups.
Tristan Tieso
COO and Program Lead
Former VP of Operations at Worrell with 15+ years of experience in medical device engineering and project management.
Lauren Fischer, MS
Program Manager
10+ years of experience managing interventional development programs at Abbott, Nextern, and Vention Medical.
Curt Goreham-Voss, PhD
Principal Engineer
Biomedical engineer with 10 years of cardiovascular device experience leading highly-technical development programs.
Lisa Pritchard
Regulatory Lead
30+ years of global regulatory experience managing IDEs, Breakthrough Device Designations, 510(k)s, De Novos, PMAs, and EUAs.
Nichole Leahy-Glass
Quality Lead
Biomedical engineer with 10+ years of global quality affairs experience and former VP of Operations and RA/QA at G&H Ortho.
Christina Portz
Clinical Lead
20+ years of clinical affairs experience and previous management roles at Philips, Covidien, and Boston Scientific.
Peter Schneider, MD
Vascular Surgeon
Co-founder of Cagent Vascular and Intact Vascular and scientific advisor to Abbott, Boston Scientific, and Medtronic.
Art Lee, MD
Interventional Cardiologist
Highly accomplished interventionalist with deep clinical research experience and advisor to many cardiovascular companies.
Brady Hatcher
Board Director
Founder of 10+ medtech startups, inventor on dozens of issued patents, and catalyst for multiple successful company exits.
JC Sun, PhD, MBA
Board Director
Extensive equity transaction experience with hundreds of millions in closings as sell-side advisor for many medtech startups.
Join Our Waiting List of Investors
We oversubscribed our last round of financing in just a few weeks, so enter your email below to avoid missing out on the next opportunity to invest.
IVL is an impressive therapy with an attractive market and I’m very excited about FastWave’s prospects.
Dr. Puneet Khanna
Interventional Cardiologist & Medtech Investor
Join Our Waiting List of Investors
We oversubscribed our last round of financing in just a few weeks, so enter your email below to avoid missing out on the next opportunity to invest.
IVL is an impressive therapy with an attractive market and I’m very excited about FastWave’s prospects.
Dr. Puneet Khanna
Interventional Cardiologist & Medtech Investor
Join Our Waiting List of Investors
We oversubscribed our last round of financing in just a few weeks, so enter your email below to avoid missing out on the next opportunity to invest.
IVL is an impressive therapy with an attractive market and I’m very excited about FastWave’s prospects.
Dr. Puneet Khanna
Interventional Cardiologist & Medtech Investor
Join Our Waiting List of Investors
We oversubscribed our last round of financing in just a few weeks, so enter your email below to avoid missing out on the next opportunity to invest.
IVL is an impressive therapy with an attractive market and I’m very excited about FastWave’s prospects.
Dr. Puneet Khanna
Interventional Cardiologist & Medtech Investor